The aim of this study is to determine whether fixation, as opposed to revision arthroplasty, can be safely used to treat reducible Vancouver B type fractures in association with a cemented collarless polished tapered femoral stem (the Exeter).

This is a retrospective cohort study of 152 operatively managed consecutive unilateral Vancouver B fractures involving Exeter stems. 130 were managed with open reduction and internal fixation (ORIF) and 22 with revision arthroplasty. Radiographs were assessed and classified by 3 observers. The primary outcome measure was revision of ≥1 component. Kaplan Meier survival analysis was performed. Logistic regression was used to identify risk factors for revision following ORIF. Secondary outcomes included any reoperation, complications, blood transfusion, length of hospital stay and mortality.

Fractures (B1 n=74 (49%); B2 n=50 (33%); and B3 n=28 (18%)) occurred at mean 6.7±10.4 years after primary THA (n=143) or hemiarthroplasty (n=15). Mean follow up was 6.5 ±2.6 years (3.2 to 12.1). Rates of revision and reoperation were significantly higher following revision arthroplasty compared to ORIF for B2 (p=0.001) fractures and B3 fractures (p=0.05). Five-year survival was significantly better following ORIF: 92% (86.4 to 97.4 95%CI) Vs 63% (41.7 to 83.3), p<0.001. No independent predictors of revision following ORIF were identified: fixation of B2 or B3 fractures was not associated with an increased risk of revision. Dislocation was the commonest mode of failure after revision arthroplasty. ORIF was associated with reduced blood transfusion requirement and reoperations, but there were no differences in medical complications, hospital stay or mortality between surgical groups.

When the bone-cement interface was intact and the fracture was anatomically reducible, Vancouver B2 fractures around Exeter stems can be treated with fixation as opposed to revision arthroplasty. Fixation of Vancouver B3 fractures can be performed in frail elderly patients without increasing revision risk.

Anterior knee pain (AKP) is the commonest complication of total knee arthroplasty (TKA). This study aims to assess whether sagittal femoral component position is an independent predictor of AKP after cruciate retaining single radius TKA without primary patellofemoral resurfacing.

From a prospective cohort of 297 consecutive TKAs, 73 (25%) patients reported AKP and 89 (30%) reported no pain at 10 years. Patients were assessed pre-operatively and at 1, 5 and 10 years using the short form 12 and Oxford Knee Score (OKS). Variables assessed included demographic data, indication, reoperation, patella resurfacing, and radiographic criteria.

Patients with AKP (mean age 67.0 (38–82), 48 (66%) female) had mean Visual Analogue Scale (VAS) Pain scores of 34.3 (range 5–100). VAS scores were 0 in patients with no pain (mean age 66.5 (41–82), 60 (67%) female). Femoral component flexion (FCF), anterior femoral offset ratio, and medial proximal tibial angle all differed significantly between patients with AKP and no pain (p<0.001), p=0.007, p=0.009, respectively). All PROMs were worse in the AKP group at 10 years (p<0.05). OKSs were worse from 1 year (p<0.05). Multivariate analysis confirmed FCF and Insall ratio <0.8 as independent predictors of AKP (R² = 0.263). Extension of ≥0.5° predicted AKP with 87% sensitivity.

AKP affects 25% of patients following single radius cruciate retaining TKA, resulting in inferior patient-reported outcome measures at 10 years. Sagittal plane positioning and alignment of the femoral component are important determinants of long-term AKP with femoral component extension being a major risk factor.

Aim

To investigate the validity of threshold values for the Oxford Hip and Knee Score (OHS and OKS) for treatment success 12 months after total knee or hip replacement.

Aim

To evaluate the association of BMI and improvement in patient-reported outcomes after TKA.

The aim of the study was to describe the failure rate of locking plates used for internal fixation of distal femoral fractures and to identify independent predictors of failure.

A consecutive series of 147 patients presenting to the study unit during an 8 year period with a distal femoral fracture were identified from a prospectively compiled trauma database. There were 117 females and 30 males, with a mean age of 70.7 years (13 to 99 years), of which 77 were periprosthetic fractures and 70 were supracondylar fractures around native knees.

There were 35 failures of fixation. The commonest cause was non-union (n=31). The survival of the plate 2 years post-surgery was 74percnt; (95percnt; CI 64percnt; to 84percnt;), which remained static to a mean follow of 5 years. There was no difference in failure of fixation according to gender (p=0.32) or if there was a periprosthetic fracture (p=0.8). Younger age (61.8 vs. 73.6 years, p=0.004), increasing level of comorbidity (p=0.02), and fracture comminution (p=0.001) were all significant predictors of failure of fixation. Cox regression analysis confirmed younger age (p=0.04), increasing comorbidity (p=0.002), and fracture comminution (p=0.002) as independent predictors of failure of fixation and non-union after adjusting for confounding.

The failure of locking plates for distal femoral fractures occurs in more than one in five patients. The independent predictors could be used to identify those patients at greatest risk of failure of the locking plate, who may benefit from alternative methods of fixation, primary bone grafting, or interventions that may aid union.

Patient function is poorly characterised following revision TKA. Modern semi-constrained implants are suggested to offer high levels of function, however, data is lacking to justify this claim.

52 consecutive aseptic revision TKA procedures performed at a single centre were prospectively evaluated; all were revision of a primary implant to a Triathlon total stabiliser prosthesis. Patients were assessed pre-operatively and at 6, 26, 52 and 104 weeks post-op. Outcome assessments were the Oxford Knee Score (OKS), range of motion, pain rating scale and timed functional assessment battery. Analysis was by repeated measures ANOVA with post-hoc Tukey HSD 95% simultaneous confidence intervals as pairwise comparison. Secondary analysis compared the results of this revision cohort to previously reported primary TKA data, performed by the same surgeons, with identical outcome assessments at equivalent time points.

Mean age was 73.23 (SD 10.41) years, 57% were male. Mean time since index surgery was 9.03 (SD 5.6) years. 3 patients were lost to follow-up. All outcome parameters improved significantly over time (p <0.001). Post-hoc analysis demonstrated that all outcomes changed between pre-op, 6 week and 26 weeks post-op assessments.

No difference was seen between primary and revision cohorts in OKS (p = 0.2) or pain scores (p=0.19). Range of motion and functional performance was different between groups over the 2 year period (p=0.03), however this was due to differing pre-operative scores, post-hoc analysis showed no difference between groups at any post-operative time point.

Patients undergoing aseptic revision TKA with semi-constrained implants made substantial improvements in OKS, pain scores, knee flexion, and timed functional performance, with the outcomes achieved comparable to those of primary TKA. High levels of function can be achieved following revision knee arthroplasty, which may be important considering the changing need for, and demographics of, revision surgery.

Summary Statement

Service industry metrics (the net promoter score) are being introduced as a measure of UK healthcare satisfaction. Lower limb arthroplasty, as a ‘service’, scores comparably with the most successful commercial organisations.

Summary Statement

Using current analysis/methodology, new implant technology is unlikely to demonstrate a large enough change in patient function to impact on the cost-effectiveness of the procedure.

The aim was to perform a cost-utility analysis of total joint replacement in the current environment.

Arthritis is a disabling condition that leads to long-term deterioration in quality of life. Total joint replacement, despite being one of the greatest advances in medicine in the modern era, has come under recent scrutiny. The National Health Service (NHS) has competing demands and resource allocation is challenging in times of economic restraint.

Patients undergoing total hip (n=348) and knee arthroplasty (n=323), from January to July 2010, were entered into a prospective arthroplasty database. A health utility score was derived from the Euroqol (EQ-5D) score preoperatively, and at one year, and was combined with individual life expectancy to derive the Quality-Adujusted-Life-Years (QALYs) gained. Predicted need for revision surgery was Incorporated in the model. The 2011–12 Scottish Tariff was used. Two-way analysis of variance was used to compare QALYs gained between procedures, while controlling for baseline differences.

The number of QALYs gained was higher in THR versus TKR (6.53 vs 4.04 years, p<0.001). The cost per QALY for THR was £1371 (95% CI £1194 to £1614) compared with £2101 (£1762 to £2620) for TKR. Predictors of an increase in QALYs gained were poorer health prior to surgery (p<0.001) and younger age (p<0.001). General health (EQ-5D VAS) showed greater improvement in THR versus TKR (p<0.001).

This study provides up to date cost-effectiveness data for total joint replacement. THR and TKR are both extremely clinically and cost-effective interventions, with costs that compare favourably with other medical interventions (e.g. laparoscopic hernia repair vs open: £55,548 per QALY; CHD primary prevention with statins: £21,000).

Introduction

Osteoarthritis continues to be a major cause of pain and disability. The pathological processes leading to the end-stage of joint degeneration remain poorly understood. Advances in radiological imaging have the potential to improve understanding of the structural and functional changes observed in OA. The aim of this study was to describe the microarchitecture of the femoral head in osteoarthritis.

Aim

To compare the results of total knee replacement in a consecutive series of morbidly obese patients (body mass index (BMI) > 40 kg/m²) with a matched group of non-obese (BMI< 30 kg/m²) patients.

Background: Chronic prosthetic joint infection is a cause of patient morbidity and can be challenging to treat. Surgeons performing revision arthroplasty of the hip and knee are confronted with a growing number of patients with extensive loss of bone stock. The use of a modular endoprosthesis is a possible method of treatment in such patients.

Aim: The purpose of this study was to assess the functional outcomes and the success of a single and two stage revision procedure in eradicating chronic prosthetic joint infection using a femoral endoprosthesis.

Methods: A prospective database was reviewed of 20 patients who underwent a proximal, total or distal femoral endoprosthetic replacement after chronic prosthetic infection. Radiographs performed at the time of latest follow up were evaluated for signs of loosening, osteomyelitis and implant failure. The functional status was assessed using the Short Form (SF)-36 health survey score, Toronto extremity salvage score (TESS) and the Enneking score.

Results: Thirteen patients underwent a single stage revision procedure and seven had been treated with a staged revision. At the latest follow up none of the 13 patients treated with a single stage procedure had evidence of ongoing infection. Of the seven patients who had a staged revision, 3 patients had evidence of ongoing infection. The mean pre operative Enneking score for the entire group was 17.1 points and this improved to 47.5 points post operatively (p< 0.0002). The mean pre operative TESS score for the entire group was 42% and this improved to 59% post operatively (p< 0.005). There was also a statistically significant improvement in all of the components of the SF-36 score.

Conclusion: We believe that the use of a modular endo-prosthesis in the treatment of chronic prosthetic joint infection is a successful and viable option in eradicating infection, preserving the limb and providing a good functional result.

Introduction To assess five-year survivorship and clinical outcome following unicompartmental knee replacement (UKR) and total knee replacement (TKR) in pre-operatively matched patient groups.

Methods From a prospective database of over 600 patients undergoing knee replacement for osteoarthritis, 70 primary Oxford UKRs (62 patients) were matched pre-operatively with 70 primary PFC TKRs (68 patients) for age, sex, body mass index, knee range of movement and Knee Society Score (KSS). The two groups were assessed at six, eighteen, thirty-six and sixty months following knee replacement and compared for survivorship of the prosthesis (with failure defined as revision for any reason or ‘worst-case’ assuming all patients lost to follow up are revised), post-operative ROM achieved and clinical outcome based on the KSS (reported as separate knee and function score).

Results Three (5 percent) patients in the UKR group and two (3 percent) in the TKR group were unavailable for follow-up at five years. Five-year survivorship based on revision for any reason was 90 percent (95 percent Confidence Interval (CI): 82 to 98) for UKR and 100 percent (95 percent CI: 100 to 100) for TKR (log rank test: p=0.009). The ‘worst-case’ five-year survivorship (assuming all patients lost to follow up are revised) was 85 percent (95 percent CI: 76 to 94) for UKR and 97 percent (95 percent CI: 93 to 100) for TKR (log rank test: p=0.02). The mean post-operative ROM achieved was 105.3 degrees following UKR and 98.3 degrees following TKR (difference 7.0 (95 percent CI 3.3 to 10.6), p< 0.001). There was no difference in the KSS between the two groups for the knee score (difference 0.1 (95 percent CI: −4.3 to 4.5), p=0.9) and function score (difference 2.6 (95 percent CI: −1.7 to 6.9), p=0.2).

Conclusion In comparable patients with osteoarthritis of the knee, survivorship remains superior for TKR at five years. The ROM achieved is greater for UKR but there is no difference in the overall clinical outcome following UKR or TKR. We believe that UKR should only be performed in carefully selected cases because mid-term clinical outcome is similar following UKR or TKR and the complication rate may be higher for UKR.

Aim To compare clinical outcome and complication rates in obese and non-obese patients five years following primary Total Knee Replacement (TKR) for osteoarthritis.

Methods 328 primary TKRs (283 patients) performed between 1995–1999 at a single institution, were followed up prospectively at intervals of 6, 18, 36 and 60 months following surgery and the clinical outcome based on the Knee Society Clinical rating system (subdivided into a Knee Score (KS) and Function score (FS)) recorded at each follow-up interval. The following complications were also recorded: peri-operative mortality, superficial wound infection, deep wound infection, deep vein thrombosis, and revision rate. Three separate comparisons were undertaken by subdividing the study sample into two sub-groups: (1) Group A comprised two subgroups based on body mass index (BMI) – Non-obese (BMI 15–30, 181 TKRs) or Obese (BMI> 30, 147 TKRs). (2) Group B comprised only female patients divided into two sub-groups based on BMI – ‘Non-obese females’ (BMI 15–30, 84 TKRs) or Obese females (BMI> 30, 87 TKRs). (3) Group C comprised two sub-groups based on body weight alone – weight < 100kg (300 TKRs) or weight > 100kg (28 TKRs). A repeated measures split-plot analysis of variance (SPANOVA) was used to evaluate the difference in the clinical outcome at five years between the sub-groups in Group A, B and C. The complication rates were also compared.

Results There was no significant difference in the KS at five years between sub-groups in Group A (p=0.2), B (p=0.2) or C (p=0.3). There was a statistically significant difference in the FS between the subgroups in Group A (p=0.01) and B (p=0.02) but the effect size (relative magnitude of the difference between means) was small (partial eta squared = 0.02 and 0.03, for Group A and B respectively). There was no significant difference in the FS between sub-groups in Group C (p=0.5). There was no significant difference in the complication rate between the sub-groups in Group A, B or C (p> 0.2 for all complications).

Conclusion Obesity does not influence clinical outcome, peri-operative mortality and complication rates five years following TKR. Further studies are required to determine the long-term success of TKR in obese patients.

Introduction and Aims: Several non-comparative studies for uni-compartmental knee replacement (UKR) and total knee replacement (TKR) have been published, but few provide a direct comparison in well-matched patients. The aim of this study was to assess five-year survivorship and the quality of outcome following UKR and TKR in pre-operatively matched patient groups.

Method: From a prospective database of over 600 patients undergoing knee replacement for osteoarthritis, 70 primary medial Oxford UKRs (62 patients) were matched pre-operatively with 70 primary Kinematic TKRs (68 patients) for age, sex, body mass index, active range of movement (ROM) and Knee Society Score (KSS). The two groups were assessed at six, 18, 36 and 60 months following knee replacement and compared for survivorship of the prosthesis (with failure defined as revision for any reason or ‘worst-case’ assuming all patients lost to follow-up are revised), quality of outcome based on the KSS (reported as separate knee and function score) and the ROM achieved.

Results: Three (4%) patients in the UKR group and two (3%) in the TKR group were unavailable for follow-up at five years. Five-year survivorship (Kaplan-Meier methodology) was significantly different for the two groups using revision for any reason as an endpoint – 90% for UKR, 100% for TKR (log-rank test, p=0.01). Assuming all patients lost to follow-up were revised, the ‘worst-case’ five-year survivorship was also significantly different for the two groups – 85% for UKR, 97% for TKR (log-rank test, p=0.02). Analysis of the KSS at six, 18, 36 and 60 months showed no significant difference between the two groups for the knee score (p=0.48) and the function score (p=0.1). The ROM achieved at five years was greater for the UKR group and the difference was statistically significant (UKR: Least square mean 105 degrees, standard error 1.2; TKR: Least square mean 98 degrees, standard error 1.2, p< 0.001).

Conclusion: In comparable patients with osteoarthritis of the knee, survivorship remains superior for TKR at five years. The ROM achieved is greater for UKR, but there is no difference in the overall quality of outcome following UKR or TKR. We believe that UKR should only be performed in carefully selected cases because mid-term functional outcome is similar following UKR or TKR and the complication rate may be higher for UKR.

Significant controversy exists with regard to the nomenclature, treatment and outcome of a group of well-differentiated lipomatous tumours sometimes labeled as atypical lipomas. The purpose of this paper is to attempt to clarify these controversies by reporting our experiences with this lesion.

The clinical features and follow-up of seventy patients with the diagnosis deep atypical lipoma (DAL) and a minimum two-year follow-up were examined.

Sixty- one patients were treated here with their primary lesion. Thirty-three were female and 28 were male. Ages ranged from 11 to 83 years (mean 57 years). They typically presented with a long history (four weeks to ten years, mean 91 weeks) and a large mass (4 to 30 centimetres, mean 18 centimetres). Most lesions were located in the thigh. Following treatment by marginal excision alone, five patients had a local recurrence (8.2%). Three recurred once and two recurred twice. No patient had a metastasis or died as a result of the tumour. No lesion dedifferentiated. Eight of the nine patients seen here with a presumed recurrence actually had a recurrent atypical lipoma. All recurrences were treated by further marginal resections and one went on to have a further recurrence. None of these patients had a metastasis and no lesion dedifferentiated. The final patient with a suspected recurrence most likely had a radiation-induced sarcoma nine years following radiotherapy after the marginal excision of a recurrent atypical lipoma.

We believe the term atypical lipoma is appropriate for these tumours, as they appear not to have any metastatic potential, merely a propensity to recur locally. The chance of dedifferentiation is small and the role of radiotherapy in the causation of dedifferentiation is uncertain. We suggest that a simple marginal resection (shelling-out) is adequate treatment for these lesions. Radiotherapy should not be used.

The purpose of this study is to investigate the causes and characteristics of the aggressive solitary bone lesion in patients over the age of forty.

Over a four year period, 318 patients over the age of forty were referred to our institution with what we would define as an aggressive solitary bone lesion. Further investigation and diagnostic biopsy as appropriate were performed in all patients. The lesions were then defined according to their radiological appearance, pathology and site. The nature of these lesions was then subdivided into several broad groups. A diagnosis of primary bone sarcoma was found in 30% of these lesions. Plasmacytoma, lymphoma and metastases accounted for 13% each. Benign bone tumours, infection and non-oncological diagnoses accounted for 9%, 6% and 16% of lesions respectively.

Aggressive solitary bone lesions are often due to primary bone sarcomas. Metastases from a previously unrecognised primary malignancy account for less than one sixth of lesions. This study emphasises the need for appropriate investigation and biopsy of the aggressive solitary bone lesion.

The purpose of this study is to emphasise the necessity for caution in assuming the diagnosis of a metastasis when a solitary bone lesion is identified following a prior malignancy.

Bone lesions occurring in patients who have previously had a malignancy are generally assumed to be a metastasis from that malignancy. We reviewed 60 patients with a previous history of malignancy, who presented with a bone lesion that was subsequently found to be a different primary sarcoma of bone. These second malignancies occurred in three distinct groups of patients.

Patients with original tumours well known to be associated with second malignancies (5%)

Inappropriate biopsy and treatment of primary bone sarcomas compromises limb salvage surgery and can affect patient mortality. We would advise referral of any aggressive solitary bone lesion to a regional bone tumour service for further assessment and biopsy rather than to assume the lesion is a metastasis.